Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Fund moves › GE HealthCare › Capital Research Global Investors cut its GEHC stake below 5% (4.6%) Fund moves
Stake · was 5.5%
Shares owned
Why it stands out The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Date of the event that required the filing Mar 31, 2026
Reporting period Not applicable
Filed with the SEC May 14, 2026 passive 5% holder
Context Change vs prior quarter Undefined
Compared with the manager's prior 13F
Tracked managers with the same change NaN
For the same quarter
0001422848-26-000057
Data quality Verified: identifiers matched exactly
Around the same time Insider buying
Their first buy on record Traded May 22 · filed 4 days later
A GE HealthCare director paid $642K out of pocket for GE HealthCare shares. 7 other people at GE HealthCare bought some too, in the same month. Shares held went up 229% with this purchase.
Insider filing
Traded May 15 · filed 4 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded May 15 · filed 4 days later
Routine share withholding; mechanical by default.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Feb 4, 2026 Company filing · Form 8-K · Results Reported its results Feb 13, 2026 5% stake Dodge & Cox reported a passive stake (13G) of 6.9% Feb 26, 2026 Company filing · Form 8-K · Material agreement, Agreement ended Signed an important agreement, and ended an important agreement (and 1 more item) Mar 13, 2026 Company filing · Form 8-K · Executive change, Reg FD Changed a top executive or board member, and shared information with investors “On March 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Kevin A. Lobo to serve as a director of the Company, effective immediately.” Mar 23, 2026 Congress Disclosed sale of GEHC — reported range $1,001 - $15,000 Mar 25, 2026 Congress Disclosed sale of GEHC — reported range $1,001 - $15,000 Mar 26, 2026 5% stake The Vanguard Group reported a passive stake (13G) Mar 27, 2026 Congress Disclosed purchase of GEHC — reported range $1,001 - $15,000 What came next Apr 29, 2026 Company filing · Form 8-K · Results Reported its results Apr 29, 2026 5% stake Vanguard Capital Management reported a passive stake (13G) of 7.3% Apr 30, 2026 Insider · 2 people Insiders: 2 purchases (~$356K) May 1, 2026 FDA Recall: Giraffe OmniBed Field Replaceable Unit (FRU), Model Numbers 6600-1056-400 and 6600-1461-500